PRL and metabolic dysfunction-associated steatotic liver disease: This analysis indicated that the differentially abundant metabolites in the DI group were all related to the prolactin signalling pathway, central carbon metabolism in cancer, protein digestion and absorption, non-alcoholic fatty liver disease, and the insulin signalling pathway (p < 0.01, frequency-distance relationship correction; Figure 5D).